News tagged with therapeutic option
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Genetics
21 hours ago |
3 / 5 (2) |
0
|
New drug targets skin cancer
A new class of drug targeting skin cancer's genetic material has been successfully tested in humans for the first time, opening the way to new treatments for a range of conditions from skin cancers to eye ...
Cancer
May 07, 2013 |
5 / 5 (1) |
0
Drug combination against NRAS-mutant melanoma discovered
A new study published online in Nature Medicine, led by scientists at The University of Texas MD Anderson Cancer Center, describes the discovery of a novel drug combination aimed at a subset of melanoma patients who curren ...
Cancer
Sep 17, 2012 |
5 / 5 (1) |
0
|
Gene regenerates heart tissue, critical finding for heart failure prevention
Researchers at UT Southwestern Medical Center have identified a specific gene that regulates the heart's ability to regenerate after injuries.
Genetics
Apr 17, 2013 |
4.7 / 5 (3) |
0
|
Study finds possible alternative to bariatric weight loss surgery
An experimental procedure successfully tested in obese laboratory rats may provide a less-invasive alternative to bariatric weight-loss surgery, researchers report online in Endocrinology.
Surgery
Apr 30, 2013 |
not rated yet |
0
Nipping metastases in the bud: A novel strategy for fighting cancer targets secondary tumors
The proliferation of metastases is often the main cause of complications and death from cancer. For the first time, researchers are looking very closely at the development of these metastases themselves, instead ...
Cancer
Dec 07, 2011 |
not rated yet |
0
|
Treatment for novel coronavirus shows promise in early lab tests
National Institutes of Health (NIH) scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating ...
Diseases, Conditions, Syndromes
Apr 18, 2013 |
not rated yet |
0
Liver cancers armed with many strategies for evading immune response
(Medical Xpress)—Researchers at Roswell Park Cancer Institute (RPCI) have published findings that help explain how a common and particularly resilient form of liver cancer evades the body's natural antitumor responses. ...
Cancer
Apr 18, 2013 |
not rated yet |
0
Preclinical muscular dystrophy data shows promise
Cedars-Sinai Heart Institute researchers have found that an experimental compound may help stem the debilitating effects of muscular dystrophy by restoring normal blood flow to muscles affected by the genetic disorder.
Medical research
Nov 08, 2012 |
4 / 5 (1) |
0
|
Researchers discover biological diversity in triple-negative breast cancer
Triple-negative breast cancers are more biologically diverse than previously believed and classification should be expanded to reflect this heterogeneity, according to University of North Carolina researchers.
Cancer
Feb 13, 2013 |
not rated yet |
0
|
Mount Sinai researcher finds timing of ADHD medication affect academic progress
A team of researchers led by an epidemiologist at Mount Sinai School of Medicine and University of Iceland has found a correlation between the age at which children with attention-deficit/hyperactivity disorder (ADHD) begin ...
Attention deficit disorders
Jun 25, 2012 |
not rated yet |
1
|
Want to avoid ED following prostate cancer surgery? Find an experienced, gentle surgeon
Prostate cancer is the most commonly diagnosed non-skin cancer in the U.S., and radical prostatectomy, the surgical removal of the prostate gland, remains the most popular therapeutic option, accounting for ...
Surgery
May 16, 2012 |
not rated yet |
0
|
Study adds to efforts to find more effective anti-inflammatory drugs
Researchers have discovered a previously unknown function for a protein that could add to the expanding arsenal of potential new drugs for battling inflammation and tissue fibrosis in a number of disease processes.
Inflammatory disorders
Sep 27, 2012 |
not rated yet |
0
|
Genetic variation contributes to pulmonary fibrosis risk
A newly published study of patients with pulmonary fibrosis has discovered multiple genetic variations that should help with future efforts to treat the disease.
Genetics
Apr 15, 2013 |
not rated yet |
0
|
Hedgehog pathway key in tamoxifen-resistant breast CA
(HealthDay)—Noncanonical Hedgehog (Hh) signaling is activated in tamoxifen-resistant tumors, and the phosphoinositide 3-kinase inhibitor/protein kinase B (PI3K/AKT) pathway plays a key role protecting Hh ...
Cancer
Nov 06, 2012 |
not rated yet |
0
